Search research articles
Contact Us
Filters
Showing results (91-100 of 130) with videos related to
Page
of 13
Sort By:
Cell Reports Methods
|
May 9, 2023
TCR sequencing and cloning methods for repertoire analysis and isolation of tumor-reactive TCRs
Raphael Genolet, Sara Bobisse, Johanna Chiffelle, et al.
Cell Reports. Medicine
|
March 5, 2021
Prediction of neo-epitope immunogenicity reveals TCR recognition determinants and provides insight into immunoediting
Julien Schmidt, Angela R Smith, Morgane Magnin, et al.
Molecular Therapy. Oncology
|
December 15, 2025
Highly efficient gene knockout in tumor-infiltrating lymphocytes by adenine base editing
Morteza Hafezi, Raphael Genolet, Leila Hadadi, et al.
Frontiers in Immunology
|
August 24, 2019
A Phase Ib Study of the Combination of Personalized Autologous Dendritic Cell Vaccine, Aspirin, and Standard of Care Adjuvant Chemotherapy Followed by Nivolumab for Resected Pancreatic Adenocarcinoma-A Proof of Antigen Discovery Feasibility in Three Patients
Michal Bassani-Sternberg, Antonia Digklia, Florian Huber, et al.
Journal of Virology
|
March 27, 2009
Comparison of human and rhesus macaque T-cell responses elicited by boosting with NYVAC encoding human immunodeficiency virus type 1 clade C immunogens
Petra Mooij, Sunita S Balla-Jhagjhoorsingh, Niels Beenhakker, et al.
Frontiers in Immunology
|
November 28, 2025
Detection of spontaneous anti-neoepitope T-cell responses in non-metastatic bladder cancer patients
Walther Brochier, Sylvain Nguyen, Valérie Cesson, et al.
Vaccine
|
May 27, 2008
EV02: a Phase I trial to compare the safety and immunogenicity of HIV DNA-C prime-NYVAC-C boost to NYVAC-C alone
Sheena McCormack, Wolfgang Stöhr, Tristan Barber, et al.
International Journal of Cancer
|
June 12, 2023
Clonal expansion of intra-epithelial T cells in breast cancer revealed by spatial transcriptomics
Lou Romanens, Prasad Chaskar, Rachel Marcone, et al.
Vaccine
|
May 27, 2008
EV01: a phase I trial in healthy HIV negative volunteers to evaluate a clade C HIV vaccine, NYVAC-C undertaken by the EuroVacc Consortium
Pierre-Alexandre Bart, Ruth Goodall, Tristan Barber, et al.
Science Advances
|
June 11, 2025
Phage display enables machine learning discovery of cancer antigen-specific TCRs
Giancarlo Croce, Rachid Lani, Delphine Tardivon, et al.
Page
of 13
Search research articles
Search
Showing results (91-100 of 130) with videos related to
Sort By:
Page
of 13
Cell Reports Methods
|
May 9, 2023
TCR sequencing and cloning methods for repertoire analysis and isolation of tumor-reactive TCRs
Raphael Genolet, Sara Bobisse, Johanna Chiffelle, et al.
Cell Reports. Medicine
|
March 5, 2021
Prediction of neo-epitope immunogenicity reveals TCR recognition determinants and provides insight into immunoediting
Julien Schmidt, Angela R Smith, Morgane Magnin, et al.
Molecular Therapy. Oncology
|
December 15, 2025
Highly efficient gene knockout in tumor-infiltrating lymphocytes by adenine base editing
Morteza Hafezi, Raphael Genolet, Leila Hadadi, et al.
Frontiers in Immunology
|
August 24, 2019
A Phase Ib Study of the Combination of Personalized Autologous Dendritic Cell Vaccine, Aspirin, and Standard of Care Adjuvant Chemotherapy Followed by Nivolumab for Resected Pancreatic Adenocarcinoma-A Proof of Antigen Discovery Feasibility in Three Patients
Michal Bassani-Sternberg, Antonia Digklia, Florian Huber, et al.
Journal of Virology
|
March 27, 2009
Comparison of human and rhesus macaque T-cell responses elicited by boosting with NYVAC encoding human immunodeficiency virus type 1 clade C immunogens
Petra Mooij, Sunita S Balla-Jhagjhoorsingh, Niels Beenhakker, et al.
Frontiers in Immunology
|
November 28, 2025
Detection of spontaneous anti-neoepitope T-cell responses in non-metastatic bladder cancer patients
Walther Brochier, Sylvain Nguyen, Valérie Cesson, et al.
Vaccine
|
May 27, 2008
EV02: a Phase I trial to compare the safety and immunogenicity of HIV DNA-C prime-NYVAC-C boost to NYVAC-C alone
Sheena McCormack, Wolfgang Stöhr, Tristan Barber, et al.
International Journal of Cancer
|
June 12, 2023
Clonal expansion of intra-epithelial T cells in breast cancer revealed by spatial transcriptomics
Lou Romanens, Prasad Chaskar, Rachel Marcone, et al.
Vaccine
|
May 27, 2008
EV01: a phase I trial in healthy HIV negative volunteers to evaluate a clade C HIV vaccine, NYVAC-C undertaken by the EuroVacc Consortium
Pierre-Alexandre Bart, Ruth Goodall, Tristan Barber, et al.
Science Advances
|
June 11, 2025
Phage display enables machine learning discovery of cancer antigen-specific TCRs
Giancarlo Croce, Rachid Lani, Delphine Tardivon, et al.
Page
of 13